aTYR PHARMA INCATYREarnings & Financial Report
Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)
aTyr Pharma is a public biotherapeutics company that is focused on researching the extracellular functionality and signaling pathways of tRNA synthetases.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Nos. of above persons | 19.35% | 14.7M | ▲ +1.98pp | 2024-10-07 |
| FMR LLC | 15.00% | 8.8M | — | 2024-02-09 |
| Point72 Asset Management, L.P. | 6.20% | 5.0M | — | 2024-10-15 |
| Logos Global Management LP | 2.10% | 1.8M | ▼ -7.80pp | 2024-11-14 |
| Laurence W. Lytton | 1.00% | 585.0K | — | 2024-02-14 |
| Stonepine Capital Management, LLC | 0.80% | 482.3K | — | 2024-02-13 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.